Optimising utilisation of GLASS data to inform cross-border antimicrobial resistance strategy is a priority.
作者信息
Pallett Scott John Charles, Charani Esmita, Lamb Georgia, Mazzella Andrea, Alqahtani Saleh A, Moore Luke Stephen Prockter
机构信息
Centre of Defence Pathology, Royal Centre for Defence Medicine, Edgbaston, Birmingham B15 2WB, UK.
Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.
出版信息
Lancet Reg Health Am. 2023 Dec 22;29:100655. doi: 10.1016/j.lana.2023.100655. eCollection 2024 Jan.
Abstract
摘要
相似文献
1
Optimising utilisation of GLASS data to inform cross-border antimicrobial resistance strategy is a priority.优化利用全球抗菌药物监测系统（GLASS）数据以指导跨境抗菌药物耐药性战略是一项优先事项。
Lancet Reg Health Am. 2023 Dec 22;29:100655. doi: 10.1016/j.lana.2023.100655. eCollection 2024 Jan.
2
Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India.印度全球抗菌药物耐药性监测系统（GLASS）重点病原体的抗菌药物敏感性概况和耐药机制。
Indian J Med Res. 2019 Feb;149(2):87-96. doi: 10.4103/ijmr.IJMR_214_18.
3
Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.2015-2020 年乌干达实施世界卫生组织全球抗菌药物耐药性监测系统：使用国家监测数据的混合方法研究。
JMIR Public Health Surveill. 2021 Oct 21;7(10):e29954. doi: 10.2196/29954.
4
Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.巴基斯坦 GLASS 优先病原体的抗微生物药物耐药性：2006-2018 年。
BMC Infect Dis. 2021 Dec 7;21(1):1231. doi: 10.1186/s12879-021-06795-0.
5
Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance.新西兰达尼丁医院的抗菌药物使用情况及其与抗菌药物耐药性的关联。
Pathology. 2006 Jun;38(3):245-8. doi: 10.1080/00313020600751069.
6
Comparison of de-duplication methods used by WHO Global Antimicrobial Resistance Surveillance System (GLASS) and Japan Nosocomial Infections Surveillance (JANIS) in the surveillance of antimicrobial resistance.比较世界卫生组织全球抗菌药物耐药性监测系统 (GLASS) 和日本医院感染监测 (JANIS) 在抗菌药物耐药性监测中使用的去重方法。
PLoS One. 2020 Jun 26;15(6):e0228234. doi: 10.1371/journal.pone.0228234. eCollection 2020.
7
Antimicrobial resistance among GLASS pathogens in Morocco: an epidemiological scoping review.摩洛哥 GLASS 病原体的抗微生物药物耐药性：一项流行病学范围界定综述。
BMC Infect Dis. 2022 May 7;22(1):438. doi: 10.1186/s12879-022-07412-4.
8
Antibiotic utilisation and resistance over the first decade of nationally funded antimicrobial stewardship programmes in Singapore acute-care hospitals.新加坡急性护理医院开展国家资助的抗菌药物管理计划的头十年中抗生素的使用和耐药情况。
Antimicrob Resist Infect Control. 2023 Aug 23;12(1):82. doi: 10.1186/s13756-023-01289-x.
9
Has Data Quality of an Antimicrobial Resistance Surveillance System in a Province of Nepal Improved between 2019 and 2022?2019年至2022年间，尼泊尔某省抗菌药物耐药性监测系统的数据质量有所提高吗？
Trop Med Infect Dis. 2023 Aug 4;8(8):399. doi: 10.3390/tropicalmed8080399.
10
Erratum: Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India.勘误：印度全球抗菌药物耐药监测系统（GLASS）重点病原体的抗菌药物敏感性概况及耐药机制
Indian J Med Res. 2019 Mar;149(3):432. doi: 10.4103/0971-5916.261122.
引用本文的文献
1
Standardization of an antimicrobial resistance surveillance network through data management.通过数据管理实现抗菌药物耐药性监测网络的标准化。
Front Cell Infect Microbiol. 2024 Jul 29;14:1411145. doi: 10.3389/fcimb.2024.1411145. eCollection 2024.
2
Surveillance infrastructure is essential to address antimicrobial resistance in the Americas.监测基础设施对于应对美洲地区的抗菌药物耐药性至关重要。
Lancet Reg Health Am. 2023 Dec 21;29:100654. doi: 10.1016/j.lana.2023.100654. eCollection 2024 Jan.
本文引用的文献
1
The contribution of human conflict to the development of antimicrobial resistance.人类冲突对抗菌药物耐药性发展的影响。
Commun Med (Lond). 2023 Oct 25;3(1):153. doi: 10.1038/s43856-023-00386-7.
2
Lives lost and disease burden related to antimicrobial resistance in the Americas can no longer be ignored.美洲地区因抗菌药物耐药性而导致的生命损失和疾病负担再也不能被忽视了。
Lancet Reg Health Am. 2023 Sep 21;26:100596. doi: 10.1016/j.lana.2023.100596. eCollection 2023 Oct.
3
Antimicrobial resistance in the Americas: a tale of multiple realities.
Lancet Reg Health Am. 2023 Sep 12;25:100594. doi: 10.1016/j.lana.2023.100594. eCollection 2023 Sep.
4
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.2019年美洲地区抗菌药物耐药性负担：一项跨国系统分析。
Lancet Reg Health Am. 2023 Aug 8;25:100561. doi: 10.1016/j.lana.2023.100561. eCollection 2023 Sep.
5
National action plans for antimicrobial resistance and variations in surveillance data platforms.国家抗菌素耐药性行动计划和监测数据平台的变化。
Bull World Health Organ. 2023 Aug 1;101(8):501-512F. doi: 10.2471/BLT.22.289403. Epub 2023 May 29.
Zotero 插件